The compound has not been subjected on the rigorous clinical tests required for approval by regulatory bodies including the FDA, meaning its basic safety and effectiveness in treating medical problems stay unproven.Comparative reports Participate in A vital part in placing conolidine within the broader context of pain administration. These research